TY - JOUR
T1 - Meningiomas with rhabdoid features lacking other histologic features of malignancy
T2 - A study of 44 cases and review of the literature
AU - Vaubel, Rachael A.
AU - Chen, Selby G.
AU - Raleigh, David R.
AU - Link, Michael J.
AU - Chicoine, Michael R.
AU - Barani, Igor
AU - Jenkins, Sarah M.
AU - Aleff, Patrice Abell
AU - Rodriguez, Fausto J.
AU - Burger, Peter C.
AU - Dahiya, Sonika
AU - Perry, Arie
AU - Giannini, Caterina
N1 - Publisher Copyright:
© 2015 American Association of Neuropathologists, Inc. All rights reserved.
PY - 2016/3/4
Y1 - 2016/3/4
N2 - The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n=22, 50%) or II (n=22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p=0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.
AB - The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n=22, 50%) or II (n=22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p=0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.
KW - Anaplastic meningioma
KW - Meningioma
KW - Rhabdoid meningioma
KW - WHO grade
UR - http://www.scopus.com/inward/record.url?scp=84961839193&partnerID=8YFLogxK
U2 - 10.1093/jnen/nlv006
DO - 10.1093/jnen/nlv006
M3 - Review article
C2 - 26705409
AN - SCOPUS:84961839193
SN - 0022-3069
VL - 75
SP - 44
EP - 52
JO - Journal of neuropathology and experimental neurology
JF - Journal of neuropathology and experimental neurology
IS - 1
ER -